Roger H. Kimmel, Director at ENDO PHARMACEUTICALS HOLDINGS INC (ENDP), sold 70,000 shares at $31.65 ($2.2M) on 2006-03-27, disclosed to the SEC on 2006-03-29.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ENDP | SELL | 2018-08-15 | $607K | — | Filing → |
| ENDP | SELL | 2017-11-17 | $63K | — | Filing → |
| PCG | BUY | 2017-09-06 | $279K | — | Filing → |